Introduction: Integrated chromatographic, no cost payload, and cytotoxicity assays permit exact DAR characterization critical to optimizing Harmless and powerful antibody-drug conjugates in cancer therapy. In the realm of targeted most cancers therapies, preserving rigorous quality standa